Company

News

JOIN OUR FREE WEBINAR: Understanding the Clinical Assessment of Abuse Potential

Posted on 28 November 2014

This free webinar will discuss the why, when and how of collecting, evaluating and interpreting abuse potential data throughout CNS drug development, including a discussion of the design, analysis and interpretation of human abuse potential studies. 

Read on

Genetic variations conferring risk of autism and schizophrenia affect cognition in controls

Posted on 28 November 2014

A recent paper by an international group of scientists and published in Nature has found that alleles of copy-number variants (CNV’s) conferring risk of autism or schizophrenia affect cognition in controls using CANTAB tests as part of their assessment.

Read on

UK Dementia Congress 2014: Economic model of timely dementia detection in the NHS

Posted on 10 November 2014

Cambridge Cognition will be presenting an economic model of timely dementia detection in the NHS at the UK Dementia Congress 2014.

Read on

Launch of CTIS-Profile 2+ enables cognitive safety testing of drugs throughout clinical development

Posted on 5 November 2014

Clinical trial professionals can now assess cognitive safety and tolerability for the first time through all phases of clinical development.  

Read on